Assay Optimization
Verified laboratory solutions for bio-marker profiling, in vitro cytotoxicity screenings, and origin-specific active validation optimized for international and Algerian trade.
Understanding local regulatory transformations, pharmaceutical self-reliance initiatives, and the surging industrial demand for standardized natural ingredients in North Africa.
Algeria's Ministry of Pharmaceutical Industry and the National Agency for Pharmaceutical Products (ANPP) have implemented stringent qualitative benchmarks. Botanical suppliers must provide verified certificates of analysis conforming to strict contaminant limits, pesticide residues, and microbial specifications.
Driven by national policy favoring domestic drug and supplement compounding over finished formulation imports, local producers require consistent bulk raw botanical extracts, APIs, and intermediate herbal compounds rather than unverified wildcrafted biomass.
Currency fluctuations and strategic import quotas necessitate optimized botanical sourcing strategies. Direct technical partnership with global CRO/CDMO operators eliminates intermediaries, mitigating inflation and raw-material adulteration risks.
From organoleptic identification to metabolomics and bioactivity-guided fractionation: how modern analytical science eliminates botanical variance.
Botanicals harvested from distinct ecological zones show severe fluctuations in therapeutic markers. We conduct seasonal profiling and geographical fingerprinting to guarantee that suppliers isolate maximum potency from raw herbs across all seasons.
Utilizing high-throughput in vitro testing platforms and cellular assays, we validate anti-inflammatory, antioxidant, and metabolic enzyme interactions, furnishing pharmaceutical buyers with definitive preclinical data packages.
Process engineering focuses on supercritical CO2 extraction, membrane separation, and resin chromatography to elevate target molecule concentrations while drastically curtailing energy consumption and eliminating hazardous organic solvents.
Decades of specialized research, hundreds of pharmaceutical clients, and fully certified laboratory protocols powering industrial botanical sourcing.
Years of Natural Medicine CRO/CDMO R&D
In-House Scientists & Analytical Technicians
Standardized Single-Herb Quality Monographs
Modernized Classical Formulations for Global Markets
A transparent technical framework designed to streamline customs clearance, laboratory verification, and ministerial filings across the Maghreb.
Every commercial delivery is accompanied by complete Common Technical Document (CTD) ready modules, including structural elucidation spectra, HPLC fingerprint validation, residual pesticide screens (USP/EP limits), and heavy metal assays.
Operating under strict bilateral NDAs and non-disclosure covenants, MedGence guarantees total isolation of private client formulations, custom extraction yields, and patented botanical synergies from third-party exposure.
Zone IVb real-time and accelerated stability evaluation data ensures that your finished botanicals, softgels, granules, or active powders maintain potency despite high temperatures and ambient humidity in Algerian storage hubs.
Connect directly with our senior analytical chemists to evaluate raw botanicals, develop tailored extraction protocols, or request a complete technical assay quotation.
Comprehensive regulatory, scientific, and supply chain insights for technical directors and international procurement executives.
Depending on the targeted botanical species and active secondary metabolites, we employ High-Performance Liquid Chromatography (HPLC-DAD/MS) for quantitative assays, High-Performance Thin-Layer Chromatography (HPTLC) for holistic visual fingerprint identity verification, and Gas Chromatography (GC-FID/MS) for volatile oils, terpenoids, and residual solvent evaluations. Every method is validated in accordance with ICH Q2(R1) and Algerian pharmacopeial standards.
Our origin and seasonal potency evaluation framework systematically samples botanicals across diverse geographical microclimates and harvesting stages. We profile the quantitative flux of key active markers (e.g., total polyphenols, saponins, alkaloids) against soil minerality and climatic stress. This enables pharmaceutical clients to secure predictable harvest windows and origin lots that deliver maximum active molecule yields.
Yes. We compile end-to-end preclinical documentation, method validation dossiers, stability assay data (Zone IVb), and batch-to-batch analytical certificates that satisfy the requirements of Algeria's Agence Nationale des Produits Pharmaceutiques (ANPP) for both active pharmaceutical substances and dietary supplements.
Intermediate raw active materials are supplied as concentrated standardized liquids, microencapsulated spray-dried powders, soft/fluid extracts, pastes, and concentrated volatile oils. Finished consumer dosage formats include enteric-coated capsules, softgels, bi-layer tablets, effervescent powders, oral solutions, and functional granules.
All laboratory screening, analytical method creation, and contract manufacturing tasks are performed under strict bilateral non-disclosure agreements (NDAs). MedGence operates on an entrusted contract research model: clients retain full intellectual property ownership, and client formulations or process blueprints are never commercialized or shared with third parties.
Yes. Our in-house research facilities conduct acute toxicity tests (LD50), chronic repeat-dose toxicity tests, in vitro cell-line cytotoxicity screenings, Ames mutagenicity tests, and focused animal disease models to substantiate both the preclinical safety profile and the biological efficacy of your natural extracts before commercial scaling.
Complete integration: botanical screening, analytical method establishment, toxicological safety, animal efficacy models, and clinical Phase I–IV trials.
Engage our cross-disciplinary team of natural product chemists, pharmacologists, and quality engineers to optimize your procurement pipeline.